Market Trends Ionis expands partnership with Sobi to include olezarsen commercialization outside the U.S. (IONS:NASDAQ)By admin8996erT0allMarch 26, 2025 Ionis Pharmaceuticals (NASDAQ:IONS) has entered into a license agreement under which Sobi receives exclusive rights in countries outside the U.S.,…
